$150K — $200K *
Xilio Therapeutics is a development-stage biotechnology company advancing next-generation cancer immunotherapies designed to improve patient outcomes by unleashing the power of the immune system selectively at the site of the tumor. The company’s tumor-selective immunotherapies are based on its proprietary technology, which maximizes the potency of proven immuno-oncology therapies and restricts their activity to the tumor to minimize peripheral side effects. The broad applicability of these therapies across cancer types means that all patients could benefit from these potentially curative medicines.
Xilio was founded in 2016, and closed a $100.5M Series B financing from blue chip venture investors in February 2020. Xilio is headquartered in Waltham, MA.
Xilio is looking for a Director, Intellectual Property to help build and manage our IP portfolio. This position reports to the Head of Legal and will play a high-profile role in a company with an exciting pipeline. The successful candidate will possess deep technical training and experience in patent preparation and prosecution with a demonstrated ability to build a biotech/pharmaceutical IP portfolio, preferably having experience with biological products. Candidate should have experience managing a rapidly evolving and dynamic R&D portfolio with the ability to manage and prioritize multiple matters with a sense of urgency. Needs the ability to operate tactically, including the capability and willingness to “be in the weeds” regularly while developing an understanding of strategic high-level projects. The ideal candidate will have experience in IP-related transactional support and business counseling for licensing and due diligence. We are willing to train the right candidate.
Valid through: 9/24/2020